376 related articles for article (PubMed ID: 25157370)
1. Progress in the identification of dengue virus entry/fusion inhibitors.
De La Guardia C; Lleonart R
Biomed Res Int; 2014; 2014():825039. PubMed ID: 25157370
[TBL] [Abstract][Full Text] [Related]
2. Carbohydrate-related inhibitors of dengue virus entry.
Hidari KI; Abe T; Suzuki T
Viruses; 2013 Feb; 5(2):605-18. PubMed ID: 23389466
[TBL] [Abstract][Full Text] [Related]
3. The Antimalarial Compound Atovaquone Inhibits Zika and Dengue Virus Infection by Blocking E Protein-Mediated Membrane Fusion.
Yamamoto M; Ichinohe T; Watanabe A; Kobayashi A; Zhang R; Song J; Kawaguchi Y; Matsuda Z; Inoue JI
Viruses; 2020 Dec; 12(12):. PubMed ID: 33371476
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Immunologically Inspired Small Molecules That Target the Viral Envelope Protein.
Lian W; Jang J; Potisopon S; Li PC; Rahmeh A; Wang J; Kwiatkowski NP; Gray NS; Yang PL
ACS Infect Dis; 2018 Sep; 4(9):1395-1406. PubMed ID: 30027735
[TBL] [Abstract][Full Text] [Related]
5. How small-molecule inhibitors of dengue-virus infection interfere with viral membrane fusion.
Chao LH; Jang J; Johnson A; Nguyen A; Gray NS; Yang PL; Harrison SC
Elife; 2018 Jul; 7():. PubMed ID: 29999491
[TBL] [Abstract][Full Text] [Related]
6. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
Torriani G; Trofimenko E; Mayor J; Fedeli C; Moreno H; Michel S; Heulot M; Chevalier N; Zimmer G; Shrestha N; Plattet P; Engler O; Rothenberger S; Widmann C; Kunz S
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626681
[TBL] [Abstract][Full Text] [Related]
7. De novo design approaches targeting an envelope protein pocket to identify small molecules against dengue virus.
Leal ES; Adler NS; Fernández GA; Gebhard LG; Battini L; Aucar MG; Videla M; Monge ME; Hernández de Los Ríos A; Acosta Dávila JA; Morell ML; Cordo SM; García CC; Gamarnik AV; Cavasotto CN; Bollini M
Eur J Med Chem; 2019 Nov; 182():111628. PubMed ID: 31472473
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein.
de Wispelaere M; Lian W; Potisopon S; Li PC; Jang J; Ficarro SB; Clark MJ; Zhu X; Kaplan JB; Pitts JD; Wales TE; Wang J; Engen JR; Marto JA; Gray NS; Yang PL
Cell Chem Biol; 2018 Aug; 25(8):1006-1016.e8. PubMed ID: 29937406
[TBL] [Abstract][Full Text] [Related]
9. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
[TBL] [Abstract][Full Text] [Related]
10. A small molecule fusion inhibitor of dengue virus.
Poh MK; Yip A; Zhang S; Priestle JP; Ma NL; Smit JM; Wilschut J; Shi PY; Wenk MR; Schul W
Antiviral Res; 2009 Dec; 84(3):260-6. PubMed ID: 19800368
[TBL] [Abstract][Full Text] [Related]
11. Viral entry inhibitors block dengue antibody-dependent enhancement in vitro.
Nicholson CO; Costin JM; Rowe DK; Lin L; Jenwitheesuk E; Samudrala R; Isern S; Michael SF
Antiviral Res; 2011 Jan; 89(1):71-4. PubMed ID: 21093488
[TBL] [Abstract][Full Text] [Related]
12. Small-Molecule Fusion Inhibitors Bind the pH-Sensing Stable Signal Peptide-GP2 Subunit Interface of the Lassa Virus Envelope Glycoprotein.
Shankar S; Whitby LR; Casquilho-Gray HE; York J; Boger DL; Nunberg JH
J Virol; 2016 Aug; 90(15):6799-807. PubMed ID: 27194767
[TBL] [Abstract][Full Text] [Related]
13. An inducible heat shock protein 70 small molecule inhibitor demonstrates anti-dengue virus activity, validating Hsp70 as a host antiviral target.
Howe MK; Speer BL; Hughes PF; Loiselle DR; Vasudevan S; Haystead TA
Antiviral Res; 2016 Jun; 130():81-92. PubMed ID: 27058774
[TBL] [Abstract][Full Text] [Related]
14. A small-molecule dengue virus entry inhibitor.
Wang QY; Patel SJ; Vangrevelinghe E; Xu HY; Rao R; Jaber D; Schul W; Gu F; Heudi O; Ma NL; Poh MK; Phong WY; Keller TH; Jacoby E; Vasudevan SG
Antimicrob Agents Chemother; 2009 May; 53(5):1823-31. PubMed ID: 19223625
[TBL] [Abstract][Full Text] [Related]
15. Receptors and routes of dengue virus entry into the host cells.
Cruz-Oliveira C; Freire JM; Conceição TM; Higa LM; Castanho MA; Da Poian AT
FEMS Microbiol Rev; 2015 Mar; 39(2):155-70. PubMed ID: 25725010
[TBL] [Abstract][Full Text] [Related]
16. A novel flavanone derivative inhibits dengue virus fusion and infectivity.
Srivarangkul P; Yuttithamnon W; Suroengrit A; Pankaew S; Hengphasatporn K; Rungrotmongkol T; Phuwapraisirisan P; Ruxrungtham K; Boonyasuppayakorn S
Antiviral Res; 2018 Mar; 151():27-38. PubMed ID: 29360474
[TBL] [Abstract][Full Text] [Related]
17. Small-molecule inhibitors of dengue-virus entry.
Schmidt AG; Lee K; Yang PL; Harrison SC
PLoS Pathog; 2012; 8(4):e1002627. PubMed ID: 22496653
[TBL] [Abstract][Full Text] [Related]
18. Identification of the phytobioactive Polygonum cuspidatum as an antiviral source for restricting dengue virus entry.
Kuo YT; Liu CH; Li JW; Lin CJ; Jassey A; Wu HN; Perng GC; Yen MH; Lin LT
Sci Rep; 2020 Oct; 10(1):16378. PubMed ID: 33009425
[TBL] [Abstract][Full Text] [Related]
19. Virion-associated phosphatidylethanolamine promotes TIM1-mediated infection by Ebola, dengue, and West Nile viruses.
Richard AS; Zhang A; Park SJ; Farzan M; Zong M; Choe H
Proc Natl Acad Sci U S A; 2015 Nov; 112(47):14682-7. PubMed ID: 26575624
[TBL] [Abstract][Full Text] [Related]
20. Dengue Virus and Its Inhibitors: A Brief Review.
Tian YS; Zhou Y; Takagi T; Kameoka M; Kawashita N
Chem Pharm Bull (Tokyo); 2018; 66(3):191-206. PubMed ID: 29491253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
